Last 7 days
3.3%
Last 30 days
1.5%
Last 90 days
3.6%
Trailing 12 Months
-20.3%
Name | Mkt Capsorted ascending | Revenue | Price %, 1M | Returns, 1Y | P/E | P/S | Rev 1-Yr | Inc 1-Yr |
---|---|---|---|---|---|---|---|---|
LARGE-CAP | ||||||||
SYK | 108.0B | 18.4B | 9.81% | 7.15% | 45.81 | 5.86 | 7.84% | 18.25% |
MDT | 107.3B | 30.8B | -1.78% | -26.78% | 26.38 | 3.49 | -3.19% | -17.38% |
ISRG | 89.4B | 6.2B | 12.38% | -15.32% | 67.62 | 14.37 | 8.97% | -22.43% |
BDX | 70.1B | 19.0B | 7.04% | -3.24% | 43.54 | 3.69 | -0.43% | -8.78% |
EW | 50.3B | 5.4B | 3.61% | -29.72% | 33.07 | 9.35 | 2.86% | 1.25% |
MID-CAP | ||||||||
SWAV | 7.2T | 489.7M | 14.55% | 4.57% | 82.2K | 16.8K | 106.51% | 2464.23% |
PEN | 10.6B | 847.1M | 7.86% | 25.46% | -5.3K | 12.54 | 13.32% | -137.89% |
GMED | 5.6B | 1.0B | -2.14% | -23.23% | 32.76 | 5.52 | 6.76% | 24.45% |
IRTC | 3.7B | 410.9M | 4.99% | -21.24% | -32.24 | 9.11 | 27.29% | -14.60% |
TNDM | 2.6B | 801.2M | 10.62% | -65.08% | -27.7 | 3.27 | 14.00% | -707.69% |
SMALL-CAP | ||||||||
SILK | 1.5B | 138.6M | -18.17% | -5.23% | -27.28 | 10.83 | 36.62% | -10.44% |
AVNS | 1.4B | 820.0M | 5.46% | -11.22% | 27.4 | 1.69 | 10.13% | 701.59% |
BLFS | 928.9M | 154.8M | -4.61% | -4.31% | -8.93 | 6 | 60.29% | -2309.58% |
CSII | 833.4M | 239.8M | 0.46% | -12.12% | -22.01 | 3.47 | -4.74% | -31.15% |
Income Statement (Last 12 Months) | (In Millions) | |||||
---|---|---|---|---|---|---|
Description | (%) Q/Q | 2022Q4 | 2022Q3 | 2022Q2 | 2022Q1 | 2021Q4 |
Revenue | 0.1% | 4,784 | 4,777 | 4,773 | 4,585 | 4,248 |
Gross Profit | -0.8% | 2,143 | 2,160 | 2,108 | 2,016 | 1,825 |
Operating Expenses | -0.2% | 2,009 | 2,013 | 1,538 | 1,591 | 1,347 |
S&GA Expenses | -0.4% | 1,417 | 1,422 | 1,444 | 1,503 | 1,270 |
R&D Expenses | 0.7% | 101 | 101 | 95.00 | 88.00 | 79.00 |
EBITDA | 0.5% | 777 | 773 | 1,177 | 957 | - |
EBITDA Margin | 0.4% | 0.16* | 0.16* | 0.25* | 0.21* | - |
Earnings Before Taxes | -39.6% | 34.00 | 56.00 | 478 | 315 | 379 |
EBT Margin | -39.7% | 0.01* | 0.01* | 0.10* | 0.07* | - |
Interest Expenses | 6.0% | 99.00 | 94.00 | 90.00 | 90.00 | 78.00 |
Net Income | -243.2% | -27.93 | -8.14 | 377 | 244 | 279 |
Net Income Margin | -242.7% | -0.01* | 0.00* | 0.08* | 0.05* | - |
Free Cahsflow | -12.4% | 349 | 399 | 472 | 397 | - |
Balance Sheet | (In Millions) | |||||
---|---|---|---|---|---|---|
Description | (%) Q/Q | 2022Q4 | 2022Q3 | 2022Q2 | 2022Q1 | 2021Q4 |
Assets | 3.0% | 10,800 | 10,490 | 11,188 | 11,424 | 11,690 |
Current Assets | 4.7% | 1,977 | 1,888 | 1,848 | 1,879 | 1,927 |
Cash Equivalents | 0.4% | 259 | 258 | 316 | 348 | 359 |
Inventory | 7.7% | 694 | 645 | 620 | 575 | 595 |
Net PPE | 6.3% | 1,671 | 1,572 | 1,573 | 1,553 | 1,522 |
Goodwill | 4.0% | 3,853 | 3,705 | 4,321 | 4,404 | 5,115 |
Liabilities | 1.6% | 4,751 | 4,676 | 4,769 | 4,879 | 5,066 |
Current Liabilities | -8.7% | 796 | 873 | 908 | 922 | 904 |
. Short Term Borrowings | -60.3% | 60.00 | 151 | 151 | 143 | 128 |
Long Term Debt | - | 2,945 | - | - | - | - |
LT Debt, Non Current | 4.4% | 3,002 | 2,874 | 2,846 | 2,945 | 3,175 |
Shareholder's Equity | 3.9% | 6,038 | 5,813 | 6,419 | 6,532 | 6,624 |
Retained Earnings | 4.5% | 1,771 | 1,695 | 2,057 | 1,999 | 1,990 |
Shares Outstanding | -0.5% | 99.00 | 100 | 100 | 100 | 100 |
Minority Interest | -10.4% | 10.00 | 11.00 | 12.00 | 12.00 | 12.00 |
Cashflow (Last 12 Months) | (In Millions) | |||||
---|---|---|---|---|---|---|
Description | (%) Q/Q | 2022Q4 | 2022Q3 | 2022Q2 | 2022Q1 | 2021Q4 |
Cashflow From Operations | -5.2% | 713 | 752 | 819 | 685 | 701 |
Share Based Compensation | -1.6% | 40.00 | 40.00 | 40.00 | 58.00 | 54.00 |
Cashflow From Investing | -9.6% | -212 | -193 | -172 | -666 | -878 |
Cashflow From Financing | 10.6% | -581 | -650 | -844 | 116 | 294 |
Dividend Payments | 2.2% | 180 | 176 | 172 | 163 | 154 |
Buy Backs | 80.4% | 182 | 101 | 70.00 | 56.00 | 28.00 |
35.4%
29.2%
0%
Y-axis is the maximum loss one would have experienced if STERIS was unfortunately bought at previous high price.
17.7%
16.2%
16.5%
11.9%
FIve years rolling returns for STERIS.
Datesorted ascending | Fund Name | Type | % Chg | $ Change | $ Held | % Portfolio |
---|---|---|---|---|---|---|
2023-03-27 | Neo Ivy Capital Management | reduced | -66.05 | -134,000 | 81,000 | 0.06% |
2023-03-23 | ETF MANAGERS GROUP, LLC | added | 4.16 | 73,944 | 545,944 | 0.03% |
2023-03-17 | American Portfolios Advisors | added | 12.41 | -36,438 | 354,010 | 0.01% |
2023-03-15 | B. Riley Wealth Advisors, Inc. | added | 16.34 | 63,025 | 284,025 | 0.01% |
2023-03-10 | VICTORY CAPITAL MANAGEMENT INC | added | 30.38 | 2,549,500 | 8,238,500 | 0.01% |
2023-03-06 | Rockefeller Capital Management L.P. | added | 20.95 | 5,346,000 | 20,917,000 | 0.10% |
2023-03-03 | TIAA, FSB | reduced | -14.87 | -16,577 | 284,423 | -% |
2023-02-28 | Voya Investment Management LLC | added | 2.61 | 797,247 | 6,511,250 | 0.01% |
2023-02-27 | Gallagher Benefit Services, Inc. | new | - | 216,446 | 216,446 | 0.04% |
2023-02-24 | SRS Capital Advisors, Inc. | reduced | -4.91 | 4,119 | 75,119 | 0.01% |
Date Filed | Name of Filer | Percent of Class | No. of Shares | Form Type | |
---|---|---|---|---|---|
Feb 10, 2023 | wcm investment management, llc | 5.6% | 5,563,771 | SC 13G/A | |
Feb 09, 2023 | vanguard group inc | 11.99% | 11,966,040 | SC 13G/A | |
Feb 08, 2023 | blackrock inc. | 8.7% | 8,710,879 | SC 13G | |
Feb 08, 2023 | massachusetts financial services co /ma/ | 5.0% | 5,038,403 | SC 13G | |
Feb 03, 2022 | blackrock inc. | 8.1% | 8,128,575 | SC 13G/A | |
Feb 11, 2021 | janus henderson group plc | 3.8% | 3,253,302 | SC 13G/A | |
Feb 10, 2021 | vanguard group inc | 10.58% | 9,025,143 | SC 13G/A | |
Feb 01, 2021 | blackrock inc. | 9.0% | 7,688,347 | SC 13G/A | |
Feb 13, 2020 | janus henderson group plc | 6.5% | 5,482,611 | SC 13G/A | |
Feb 06, 2020 | blackrock inc. | 8.7% | 7,337,284 | SC 13G |
Fair Value | Very Pessimistic | Pessimistic | Base Case | Optimistic | Very Optimistic |
---|---|---|---|---|---|
Very Low Inflation | 93.54 -51.10% | 124.94 -34.68% | 221.37 15.73% | 295.34 54.40% | 363.68 90.13% |
Current Inflation | 86.36 -54.85% | 113.22 -40.81% | 195.01 1.95% | 256.43 34.06% | 313.07 63.67% |
Very High Inflation | 77.57 -59.45% | 99.18 -48.15% | 164.28 -14.12% | 211.75 10.70% | 255.45 33.55% |
Date Filed | Form Type | Document | |
---|---|---|---|
Mar 07, 2023 | 4 | Insider Trading | |
Feb 17, 2023 | 4 | Insider Trading | |
Feb 10, 2023 | SC 13G/A | Major Ownership Report | |
Feb 09, 2023 | SC 13G/A | Major Ownership Report | |
Feb 08, 2023 | SC 13G | Major Ownership Report | |
Feb 08, 2023 | SC 13G | Major Ownership Report | |
Feb 08, 2023 | 8-K | Current Report | |
Feb 08, 2023 | 10-Q | Quarterly Report |
Datesorted ascending | Name | Buy/Sell | $ Value | Avg. Price | # Shares | Title |
---|---|---|---|---|---|---|
2023-03-03 | Majors Cary L | sold | -218,742 | 190 | -1,150 | svp and president, healthcare |
2023-02-15 | Breeden Richard C | acquired | 204,535 | 43.92 | 4,657 | - |
2022-12-02 | Xilas Andrew | acquired | - | - | 333 | svp and gm, dental |
2022-12-02 | Xilas Andrew | sold (taxes) | -18,807 | 191 | -98.00 | svp and gm, dental |
2022-12-01 | Majors Cary L | sold | -308,016 | 192 | -1,600 | svp and president, healthcare |
2022-10-10 | Xilas Andrew | sold (taxes) | -25,115 | 168 | -149 | svp and gm, dental |
2022-10-10 | Xilas Andrew | acquired | - | - | 503 | svp and gm, dental |
2022-10-07 | Xilas Andrew | acquired | - | - | 606 | svp and gm, dental |
2022-10-07 | Xilas Andrew | sold (taxes) | -30,464 | 170 | -179 | svp and gm, dental |
2022-10-03 | Zangerle John Adam | sold (taxes) | -15,476 | 170 | -91.00 | sr. vp, gen counsel, and sec. |
CONSOLIDATED STATEMENTS OF OPERATIONS (unaudited) - USD ($) $ in Thousands | 3 Months Ended | 6 Months Ended | ||
---|---|---|---|---|
Sep. 30, 2022 | Sep. 30, 2021 | Sep. 30, 2022 | Sep. 30, 2021 | |
Revenues: | ||||
Revenues | $ 1,200,517 | $ 1,196,985 | $ 2,357,008 | $ 2,165,407 |
Fair value adjustment related to convertible debt liability | 0 | 4,883 | 0 | 27,806 |
Cost of revenues: | ||||
Total cost of revenues | 668,182 | 716,641 | 1,306,875 | 1,258,781 |
Gross Profit | 532,335 | 480,344 | 1,050,133 | 906,626 |
Operating expenses: | ||||
Selling, general, and administrative | 323,195 | 344,799 | 657,821 | 738,551 |
2591744000 | 490,565 | 0 | 490,565 | 0 |
Research and development | 24,928 | 18,832 | 49,679 | 37,024 |
Restructuring Costs | 62 | 210 | 88 | 224 |
Total operating expenses | 838,750 | 363,841 | 1,198,153 | 775,799 |
Income from operations | (306,415) | 116,503 | (148,020) | 130,827 |
Non-operating expenses, net: | ||||
Interest expense | 26,123 | 23,036 | 48,797 | 44,848 |
Interest income and miscellaneous expense | 524 | (1,023) | 1,294 | (2,457) |
Total non-operating expenses, net | 26,647 | 26,896 | 50,091 | 70,197 |
Income before income tax expense | (333,062) | 89,607 | (198,111) | 60,630 |
Income tax expense | (17,831) | 19,982 | 6,365 | 12,907 |
Net Income | (315,231) | 69,625 | (204,476) | 47,723 |
Less: Net Income Attributable to Noncontrolling Interest | 54 | (186) | (453) | (281) |
Net income (loss) attributable to shareholders | $ (315,285) | $ 69,811 | $ (204,023) | $ 48,004 |
Net income per common share [Abstract] | ||||
Basic | $ (3.15) | $ 0.70 | $ (2.04) | $ 0.51 |
Diluted | (3.15) | 0.69 | (2.04) | 0.50 |
Cash dividends declared per common share outstanding | $ 0.47 | $ 0.43 | $ 0.90 | $ 0.83 |
Product [Member] | ||||
Revenues: | ||||
Revenues | $ 666,394 | $ 685,238 | $ 1,303,470 | $ 1,174,517 |
Cost of revenues: | ||||
Cost of Goods and Services Sold | 351,079 | 427,484 | 683,934 | 698,890 |
Service [Member] | ||||
Revenues: | ||||
Revenues | 534,123 | 511,747 | 1,053,538 | 990,890 |
Cost of revenues: | ||||
Cost of Goods and Services Sold | $ 317,103 | $ 289,157 | $ 622,941 | $ 559,891 |
CONSOLIDATED BALANCE SHEETS (unaudited) - USD ($) $ in Thousands | Sep. 30, 2022 | Mar. 31, 2022 |
---|---|---|
Current assets: | ||
Cash and cash equivalents | $ 258,259 | $ 348,320 |
Accounts receivable (net of allowances of $22,196 and $24,371 respectively) | 780,113 | 799,041 |
Inventories, net | 644,936 | 574,999 |
Prepaid expenses and other current assets | 204,991 | 156,637 |
Total current assets | 1,888,299 | 1,878,997 |
Property, plant, and equipment, net | 1,572,398 | 1,552,576 |
Operating Lease, Right-of-Use Asset | 174,073 | 188,480 |
Goodwill | 3,705,140 | 4,404,343 |
Intangible Assets, Net (Excluding Goodwill) | 3,077,492 | 3,328,537 |
Other assets | 72,234 | 70,661 |
Total assets | 10,489,636 | 11,423,594 |
Current liabilities: | ||
Accounts payable | 233,308 | 225,737 |
Accrued income taxes | 16,661 | 26,873 |
Accrued payroll and other related liabilities | 133,839 | 183,721 |
Capital Lease Obligations, Current | 33,968 | 36,472 |
Short-term Debt | 151,000 | 142,875 |
Accrued expenses and other | 304,039 | 306,544 |
Total current liabilities | 872,815 | 922,222 |
Long-term indebtedness | 2,873,936 | 2,945,481 |
Deferred Income Taxes and Other Tax Liabilities, Noncurrent | 710,087 | 780,619 |
Capital Lease Obligations, Noncurrent | 143,451 | 155,056 |
Other Liabilities, Noncurrent | 75,900 | 75,579 |
Total liabilities | 4,676,189 | 4,878,957 |
Commitments and contingencies (see Note 8) | ||
Common shares, with $0.001 par value; 500,000 authorized; 99,868 shares issued; and 100,067 shares outstanding | 4,705,118 | 4,742,920 |
Retained earnings | 1,695,087 | 1,999,244 |
Accumulated other comprehensive income | (598,148) | (209,808) |
Total shareholders' equity | 5,802,057 | 6,532,356 |
Noncontrolling interest | 11,390 | 12,281 |
Total equity | 5,813,447 | 6,544,637 |
Total liabilities and equity | $ 10,489,636 | $ 11,423,594 |